Hyperuricemia: Difference between revisions

Jump to navigation Jump to search
 
Line 47: Line 47:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Drug Side Effect'''
| '''Drug Side Effect'''
|bgcolor="Beige"| [[Ciclosporin]], [[Cytarabine]],[[Epirubicin ]], [[Ethambutol]], [[Flurbiprofen]], [[Hydrochlorothiazide]], [[Ibrutinib]],  [[Nelarabine]], [[Nizatidine]],[[Pergolide]], [[Pramipexole]], [[Pyrazinamide]], [[Romidepsin]], [[Siltuximab]], [[Thalidomide]], [[Thioguanine]]
|bgcolor="Beige"| [[Ciclosporin]], [[Cytarabine]],[[Epirubicin ]], [[Ethambutol]], [[Ethacrynic Acid]], [[Flurbiprofen]], [[Hydrochlorothiazide]], [[Ibrutinib]],  [[Nelarabine]], [[Nizatidine]],[[Pergolide]], [[Pramipexole]], [[Pyrazinamide]], [[Romidepsin]], [[Siltuximab]], [[Thalidomide]], [[Thioguanine]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"

Latest revision as of 17:14, 21 April 2015

Template:DiseaseDisorder infobox

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


WikiDoc Resources for Hyperuricemia

Articles

Most recent articles on Hyperuricemia

Most cited articles on Hyperuricemia

Review articles on Hyperuricemia

Articles on Hyperuricemia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hyperuricemia

Images of Hyperuricemia

Photos of Hyperuricemia

Podcasts & MP3s on Hyperuricemia

Videos on Hyperuricemia

Evidence Based Medicine

Cochrane Collaboration on Hyperuricemia

Bandolier on Hyperuricemia

TRIP on Hyperuricemia

Clinical Trials

Ongoing Trials on Hyperuricemia at Clinical Trials.gov

Trial results on Hyperuricemia

Clinical Trials on Hyperuricemia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hyperuricemia

NICE Guidance on Hyperuricemia

NHS PRODIGY Guidance

FDA on Hyperuricemia

CDC on Hyperuricemia

Books

Books on Hyperuricemia

News

Hyperuricemia in the news

Be alerted to news on Hyperuricemia

News trends on Hyperuricemia

Commentary

Blogs on Hyperuricemia

Definitions

Definitions of Hyperuricemia

Patient Resources / Community

Patient resources on Hyperuricemia

Discussion groups on Hyperuricemia

Patient Handouts on Hyperuricemia

Directions to Hospitals Treating Hyperuricemia

Risk calculators and risk factors for Hyperuricemia

Healthcare Provider Resources

Symptoms of Hyperuricemia

Causes & Risk Factors for Hyperuricemia

Diagnostic studies for Hyperuricemia

Treatment of Hyperuricemia

Continuing Medical Education (CME)

CME Programs on Hyperuricemia

International

Hyperuricemia en Espanol

Hyperuricemia en Francais

Business

Hyperuricemia in the Marketplace

Patents on Hyperuricemia

Experimental / Informatics

List of terms related to Hyperuricemia

Overview

Hyperuricemia (American English), or hyperuricaemia (British English), is the presence of high levels of uric acid in the blood. The upper end of the normal range is 360 micromol/L (6 mg/dL) for women and 400 micromol/L (6.8 mg/dL) for men. [1]

Causes

Hyperuricemia is caused either by accelerated generation of uric acid through purine metabolism or by impaired excretion in the kidney, or by high levels of fructose in the diet.[2][3]

Consumption of purine-rich diets is one of the main causes of hyperuricemia. Other dietary causes are ingestion of high protein and fat, and starvation. Starvation results in the body metabolizing its own muscle mass for energy, in the process releasing purines into the bloodstream. Purine bases composition of foods varies. Foods with higher content of purine bases adenine and hypoxanthine are suggested to be more potent in exacerbating hyperuricemia.[4]

Humans lack urate oxidase, an enzyme which degrades uric acid. Increased levels predispose for gout and (if very high) renal failure. Apart from normal variation (with a genetic component), tumor lysis syndrome produces extreme levels of uric acid, mainly leading to renal failure. The Lesch-Nyhan syndrome is also associated with extremely high levels of uric acid. The Metabolic syndrome often presents with hyperuricemia, while a hyperuricemic syndrome is also common in Dalmatian dogs.

Causes by Organ System

Cardiovascular No underlying causes
Chemical/Poisoning No underlying causes
Dental No underlying causes
Dermatologic No underlying causes
Drug Side Effect Ciclosporin, Cytarabine,Epirubicin , Ethambutol, Ethacrynic Acid, Flurbiprofen, Hydrochlorothiazide, Ibrutinib, Nelarabine, Nizatidine,Pergolide, Pramipexole, Pyrazinamide, Romidepsin, Siltuximab, Thalidomide, Thioguanine
Ear Nose Throat No underlying causes
Endocrine No underlying causes
Environmental No underlying causes
Gastroenterologic No underlying causes
Genetic No underlying causes
Hematologic No underlying causes
Iatrogenic No underlying causes
Infectious Disease No underlying causes
Musculoskeletal/Orthopedic No underlying causes
Neurologic No underlying causes
Nutritional/Metabolic No underlying causes
Obstetric/Gynecologic No underlying causes
Oncologic No underlying causes
Ophthalmologic No underlying causes
Overdose/Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal/Electrolyte No underlying causes
Rheumatology/Immunology/Allergy No underlying causes
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous No underlying causes

Treatment

See also

External links

References

  1. Chizyński K, Rózycka M (2005). "Hyperuricemia". Pol. Merkur. Lekarski (in Polish). 19 (113): 693–6. PMID 16498814.
  2. Nakagawa T, Hu H, Zharikov S; et al. (2006). "A causal role for uric acid in fructose-induced metabolic syndrome". Am. J. Physiol. Renal Physiol. 290 (3): F625–31. doi:10.1152/ajprenal.00140.2005. PMID 16234313.
  3. Mayes PA (1993). "Intermediary metabolism of fructose". Am. J. Clin. Nutr. 58 (5 Suppl): 754S–765S. PMID 8213607.
  4. Brule, D. Sarwar, G. and Savoie (1992). "Changes in Serum Uric Acid Levels in Normal Human Subjects Fed Purine-Rich Foods Containing Different Amounts of Adenine and Hypoxanthine". Journal of American College of Nutrition. 11 (3): 353–358.
  5. Becker MA, Schumacher HR, Wortmann RL; et al. (2005). "Febuxostat compared with allopurinol in patients with hyperuricemia and gout". N. Engl. J. Med. 353 (23): 2450–61. doi:10.1056/NEJMoa050373. PMID 16339094.


Template:Metabolic pathology

de:Hyperurikämie


Template:WikiDoc Sources